Therapeutic Approaches Targeting Pathological Tau Aggregates.

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Neurodegenerative diseases are rising, marked by tau aggregate accumulation.
• Historically, research focused on neurofibrillary tangles, but soluble tau oligomers are now recognized as the most toxic species.
• Current treatments for these tauopathies are ineffective.

Purpose of the Study:

• To review the progress in developing therapeutic agents targeting toxic tau species.
• To highlight the potential of specific anti-tau strategies for treating neurodegenerative diseases.

Main Methods:

• Review of pre-clinical evaluations of various anti-tau therapeutics.
• Analysis of strategies including upstream modulators, protein chaperones, small molecule inhibitors, and immunotherapy.
• Evaluation of agents targeting specific toxic tau aggregates.

Main Results:

• Soluble tau oligomers are identified as the primary toxic species in disease.
• Small molecules inhibiting aggregation and immunotherapy targeting toxic tau aggregates show significant advancement.
• Upstream modulators and protein chaperones present potential benefits but also limitations like side effects or incomplete elimination of toxic tau.

Conclusions:

• Targeting specific toxic tau species, particularly oligomers, is a promising therapeutic strategy.
• Immunotherapy and small molecule inhibitors represent the most advanced approaches for eliminating toxic tau.
• Continued research offers hope for effective treatments for tau-related neurodegenerative diseases.